Literature DB >> 9124801

Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds.

B Soong1, C Cheng, R Liu, D Shan.   

Abstract

Machado-Joseph disease, an autosomal dominant multisystem motor degeneration, has been described mainly in people of Portuguese descent. Our report documents the presence of Machado-Joseph disease in the Chinese population, based on the specific molecular marker of a CAG repeat array in the 3' end of the MJD gene. We screened 21 Chinese families with dominant spinocerebellar ataxia. The results showed that Machado-Joseph disease with CAG expansion accounted for 52% of families with autosomal dominant cerebellar ataxia in this series. The clinical characteristics, besides the well-documented cerebellar ataxia, dysarthria, nystagmus, corticospinal dysfunctions, a variable degree of facial muscle fasciculation, and proprioceptive loss, included loss of optokinetic nystagmus and autonomic nervous system dysfunction. The CAG repeat number in the MJD gene ranged from 14 to 39 among normal alleles, and from 63 to 81 among MJD alleles. There was a strong inverse correlation (gamma = -0.77) between number of CAG repeats and age at symptom onset, accounting for 60% of the variance of age at onset. A strong clinical anticipation of age at onset existed in successive generations. Mild instabilities of expanded CAG repeat numbers during meiotic transmission occurred, with no significant difference according to the gender of the transmitting parent. Finally, brain metabolism in Machado-Joseph disease, studied with positron emission tomography, was characterized by significant progressive regional hypometabolism in the occipital cortex, as well as the cerebellar hemispheres, vermis, and brainstem.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124801     DOI: 10.1002/ana.410410407

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

2.  Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease.

Authors:  B W Soong; R S Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

3.  Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Lívia Almeida Dutra; André Carvalho Felício; Thaís Minett; Patrícia Weisman; Ruth F Santos-Galduroz; Paulo Henrique F Bertolucci; Alberto Alain Gabbai; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

Review 4.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

5.  Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6 : a voxel-based FDG-positron emission tomography analysis.

Authors:  Po-Shan Wang; Ren-Shyan Liu; Bang-Hung Yang; Bing-Wen Soong
Journal:  J Neurol       Date:  2007-04-30       Impact factor: 4.849

Review 6.  Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

Authors:  Meng-Ling Chen; Chih-Chun Lin; Liana S Rosenthal; Puneet Opal; Sheng-Han Kuo
Journal:  J Neurol Sci       Date:  2021-04-01       Impact factor: 3.181

Review 7.  Spinocerebellar ataxia clinical trials: opportunities and challenges.

Authors:  Sarah M Brooker; Chandrakanth Reddy Edamakanti; Sara M Akasha; Sheng-Han Kuo; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2021-05-21       Impact factor: 4.511

8.  miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3.

Authors:  Rui Jorge Nobre; Diana D Lobo; Carina Henriques; Sonia P Duarte; Sara M Lopes; Ana C Silva; Miguel M Lopes; Fanny Mariet; Lukas K Schwarz; M S Baatje; Valerie Ferreira; Astrid Vallès; Luis Pereira de Almeida; Melvin M Evers; Lodewijk J A Toonen
Journal:  Nucleic Acid Ther       Date:  2021-12-07       Impact factor: 4.244

Review 9.  Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.

Authors:  Melvin M Evers; Lodewijk J A Toonen; Willeke M C van Roon-Mom
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

10.  Clinical analysis of adult-onset spinocerebellar ataxias in Thailand.

Authors:  Pairoj Boonkongchuen; Sunsanee Pongpakdee; Panitha Jindahra; Chutima Papsing; Powpong Peerapatmongkol; Suppachok Wetchaphanphesat; Supachai Paiboonpol; Charungthai Dejthevaporn; Surat Tanprawate; Angkana Nudsasarn; Chanchai Jariengprasert; Dittapol Muntham; Atiporn Ingsathit; Teeratorn Pulkes
Journal:  BMC Neurol       Date:  2014-04-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.